Alnylam Pharma (ALNY) Misses Q3 EPS by 42c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 159.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $159.89 | 52 Week High | $109.10 | |||
| Open | $159.89 | 52 Week Low | $31.38 | |||
| Day High | $159.89 | P/E | N/A | |||
| Day Low | $159.89 | EPS | $-1.45 | |||
| Volume | 139,886 | |||||
